Comparative efficacy and tolerability of currently approved incretin mimetics: a systematic analysis of placebo-controlled clinical trials
Kang YM, Punov V, Lim S, Nauck MA
Diabetes Obes Metab. Pub. online 11 Apr 2025.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Kang YM, Punov V, Lim S, Nauck MA
Diabetes Obes Metab. Pub. online 11 Apr 2025.
Leggi
O’Hara DV, Jardine MJ
Diabetes Obes Metab. Pub. online 8 Apr 2025.
Leggi
Latres E, Plum-Moerschel L, Murugesan SMN, et al.
Diabetes Obes Metab. Pub. online 10 Apr 2025.
Leggi
Böhm M, Butler J, Coats A, et al.
Eur Heart J. 2025;46(14):1304-1317.
Leggi
Freckmann G, Wehrstedt S, Eichenlaub M, et al.
Diabetes Care. 2025:dc250129.
Leggi
Marx N, Deanfield JE, Mann JFE, et al.
Circulation. Pub. online 29 Mar 2025.
Leggi
Wagh R, Hatem G, Andersson J, et al.
Diabetologia. Pub. online 2 Apr 2025.
Leggi
Billings LK, Winne L, Sharma P, et al.
Ann Intern Med. Pub. online 2 Apr 2025.
Leggi
Li JX, Hsu TJ, Lin HJ, et al.
JAMA Netw Open. 2025;8(3):e252577.
Leggi
McEvoy RP, Newman C, Egan AM, Dunne FP
Diabetes Obes Metab. Pub. online 2 Apr 2025.
Leggi